Suppr超能文献

术前给予地塞米松降低甲状腺切除术后恶心呕吐发生率:药物剂量的系统评价和荟萃分析

Preoperative dexamethasone administration in reducing the incidence of nausea and vomiting after thyroidectomy: a systematic review and meta-analysis of drug dosage.

作者信息

Ye Hongyan, Gou Juxiang, Li Shulian, Ji Qiang

机构信息

Department of Thyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.

Department of Medical Aesthetics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.

出版信息

Gland Surg. 2024 Feb 29;13(2):189-198. doi: 10.21037/gs-23-260. Epub 2024 Feb 23.

Abstract

BACKGROUND

Postoperative nausea and vomiting (PONV) are key contributors to the delay of recovery and cause patients' considerable discomfort. This study aimed to evaluate the influence of a specific dexamethasone dosage on PONV incidence, with a secondary objective of assessing its impact on postoperative pain in patients undergoing thyroid surgery.

METHODS

A meta-analysis was performed to examine the effects of preoperatively administering various doses of dexamethasone in combination with saline on PONV and pain relief in patients undergoing thyroidectomy. Relevant trials published before December 30, 2022, were searched in the PubMed, Embase, Cochrane Library, and Web of Science databases. The collected data were analyzed using RevMan 5.3 software (Cochrane), and a random-effects model or fixed-effects model was employed to conduct the meta-analysis.

RESULTS

Our meta-analysis included 11 randomized controlled trials (RCTs) with a total of 1,544 participants. The results suggested that administering dexamethasone at a dosage of 8-10 mg can reduce the incidence of PONV in patients after thyroid surgery [odds ratio (OR) 0.27; 95% CI: 0.15-0.50; I=82%; P<0.0001]. Additionally, administering dexamethasone at a dosage of 8-10 mg was found to be significantly more effective in reducing the incidence of PONV than was a dosage of 4-5 mg (OR 0.39; 95% CI: 0.19-0.80; I=29%; P=0.01). The study also revealed that administering dexamethasone at a dosage of 8-10 mg can significantly reduce pain in patients undergoing thyroidectomy [mean difference (MD): -1.19; 95% CI: -1.97 to -0.41; I=96%; P=0.003]. However, administering dexamethasone at a dosage of 4-5 mg did not significantly reduce pain (MD: -0.27; 95% CI: -1.00 to 0.45; I=0%; P=0.46) according to the subgroup analysis. Our study found that the intervention of administering dexamethasone did not have a significant impact on the consumption of analgesic drugs (MD: -0.19; 95% CI: -0.45 to 0.08; I=62%; P=0.16).

CONCLUSIONS

A preoperative single dose of 8-10 mg of dexamethasone can significantly reduce PONV and the requirement for additional antiemetic medications, as well as alleviate postoperative pain after thyroidectomy. However, more RCTs should be conducted to determine the effects of varied dexamethasone dosages, particularly 4-5 mg, on the incidence of PONV and pain.

摘要

背景

术后恶心呕吐(PONV)是导致恢复延迟的关键因素,会给患者带来极大不适。本研究旨在评估特定剂量地塞米松对PONV发生率的影响,其次要目的是评估其对甲状腺手术患者术后疼痛的影响。

方法

进行一项荟萃分析,以研究术前给予不同剂量地塞米松联合生理盐水对甲状腺切除术患者PONV及疼痛缓解的影响。在PubMed、Embase、Cochrane图书馆和Web of Science数据库中检索2022年12月30日前发表的相关试验。使用RevMan 5.3软件(Cochrane)对收集的数据进行分析,并采用随机效应模型或固定效应模型进行荟萃分析。

结果

我们的荟萃分析纳入了11项随机对照试验(RCT),共1544名参与者。结果表明,给予8 - 10mg剂量的地塞米松可降低甲状腺手术后患者的PONV发生率[比值比(OR)0.27;95%置信区间:0.15 - 0.50;I² = 82%;P < 0.0001]。此外,发现给予8 - 10mg剂量的地塞米松在降低PONV发生率方面比4 - 5mg剂量显著更有效(OR 0.39;95%置信区间:0.19 - 0.80;I² = 29%;P = 0.01)。该研究还表明,给予8 - 10mg剂量的地塞米松可显著减轻甲状腺切除术患者的疼痛[平均差(MD): - 1.19;95%置信区间: - 1.97至 - 0.41;I² = 96%;P = 0.003]。然而,根据亚组分析,给予4 - 5mg剂量的地塞米松并未显著减轻疼痛(MD: - 0.27;95%置信区间: - 1.00至0.45;I² = 0%;P = 0.46)。我们的研究发现,给予地塞米松的干预对镇痛药的使用没有显著影响(MD: - 0.19;95%置信区间: - 0.45至0.08;I² = 62%;P = 0.16)。

结论

术前单次给予8 - 10mg地塞米松可显著降低PONV及额外使用止吐药物的需求,并减轻甲状腺切除术后的疼痛。然而,应进行更多的随机对照试验以确定不同剂量的地塞米松,特别是4 - 5mg,对PONV发生率和疼痛的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验